NEW YORK , May 27, 2024 /PRNewswire/ -- IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix ® portfolio of ultrapure alginate biopolymers could revolutionize regenerative medicine and 3D cell culture applications. At the 12 th World Biomaterials Congress (WBC), IFF Pharma Solutions will showcase a first-of-its-kind alginate hydrogel system that self-gels, offering a minimally invasive way to deliver therapeutics.
The company will then reveal how its unique porous alginate foam scaffolds can be utilized for 3D cell culture at the TERMIS World Congress. Breakthrough alginate hydrogel system in the spotlight at WBC At WBC in Daegu, South Korea , May 26-31 , booth #74, visitors will learn how IFF is breaking boundaries in the biotech space with novel alginate biopolymer technologies. During a poster session on May 28 at 06:00 PM (Korean standard time), Caroline Cooreman , global business development & product manager, Biotechnology, IFF Pharma Solutions, will reveal groundbreaking alginate hydrogel system that self-gels within minutes after injection.
This is enabled by combining a calcium alginate suspension with soluble sodium alginate. The resulting self-gelling hydrogel system could transform regenerative medicine by providing a minimally invasive alternative to surgical implantation procedures for.
